Latest updates for Cladribine

Fresh curated links around cladribine are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Cladribine
  • Drilling Down on Cladribine biology
  • Cladribine, TA-GVHD, blood irradiation

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

multiple-sclerosis-research.org /1 month ago

Cladribine

We talked about effects of CD20 on CNS cells. The paper today helps support the view of the event in the brain as it relates to cladribine. It shows that cladribine is getting MS u...

Read source
multiple-sclerosis-research.org /1 month ago

Drilling Down on Cladribine biology

This study uses high end technology to delve into the “unclear” and the conclusion is that cladribine gives long-term depletion of memory B cells and then we can say “Should have g...

Read source
multiple-sclerosis-research.org /1 week ago

Cladribine, TA-GVHD, blood irradiation

Irradiation of cellular blood components prevents transfusion-associated graft-versus-host disease (TA-GVHD). An overview of what TA-GVHD is can be found on slides 3 & 4 of thi...

Read source
multiple-sclerosis-research.org /1 month ago

CLADLad time Middle Eastern Style

ProfK is a CladLad and has been flying the flag for many years. I put this paper up as it reinforces what I was saying about breaks after anti-CD20. Someone asked me if we will eve...

Read source
multiplesclerosisnewstoday.com /1 week ago

Mavenclad may pull double duty for MS and other autoimmune conditions

In addition to controlling multiple sclerosis (MS), the approved therapy Mavenclad (cladribine) may also help manage certain coexisting autoimmune diseases, potentially allowing so...

Read source
multiplesclerosisnewstoday.com /1 month ago

Latest preclinical data support promise of CAR-M cell therapy LIB820

Liberate Bio’s investigational CAR-M cell therapy LIB820 may help successfully eliminate disease-driving B-cells in autoimmune diseases such as multiple sclerosis (MS) without caus...

Read source
drugs.com /1 month ago

Two-Pill Combo Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML

FRIDAY, June 5, 2026 — An already available two-pill combo treats leukemia just as well as IV drugs, which should make cancer treatment easier on older adults, a new clinical tria...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Cladribine

multiple-sclerosis-research.org

Recent coverage from public sources
Public source

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source

drugs.com

Recent coverage from public sources
Public source